{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:41:26Z","timestamp":1792575686057,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"DOI":"10.1007\/s10840-026-02263-4","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T10:26:40Z","timestamp":1771496800000},"page":"1849-1858","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Outcomes of individual DOACs vs. VKAs in AF patients with frailty: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"69","author":[{"given":"Travis","family":"Quevillon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Amlogu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratika","family":"Parkash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason G","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A","family":"Jackevicius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff S","family":"Healey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis T","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Shurrab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"2263_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2018.04.023","volume":"56","author":"U Junius-Walker","year":"2018","unstructured":"Junius-Walker U, Onder G, Soleymani D, et al. The essence of frailty: A systematic review and qualitative synthesis on frailty concepts and definitions. Eur J Intern Med. 2018;56:3\u201310. https:\/\/doi.org\/10.1016\/j.ejim.2018.04.023.","journal-title":"Eur J Intern Med"},{"issue":"8","key":"2263_CR2","doi-asserted-by":"publisher","first-page":"E487","DOI":"10.1503\/CMAJ.101271","volume":"183","author":"K Rockwood","year":"2011","unstructured":"Rockwood K, Song X, Mitnitski A. Changes in relative fitness and frailty across the adult lifespan: evidence from the Canadian National population health survey. CMAJ. 2011;183(8):E487\u201394. https:\/\/doi.org\/10.1503\/CMAJ.101271.","journal-title":"CMAJ"},{"key":"2263_CR3","doi-asserted-by":"publisher","unstructured":"Proietti M, Romiti GF, Raparelli V, et al. Frailty prevalence and impact on outcomes in patients with atrial fibrillation: a systematic review and meta-analysis of 1,187,000 patients. Ageing Res Rev. 2022;79. https:\/\/doi.org\/10.1016\/j.arr.2022.101652.","DOI":"10.1016\/j.arr.2022.101652"},{"issue":"2","key":"2263_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GYH Lip","year":"2010","unstructured":"Lip GYH, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro heart survey on atrial fibrillation. Chest. 2010;137(2):263\u201372. https:\/\/doi.org\/10.1378\/chest.09-1584.","journal-title":"Chest"},{"issue":"12","key":"2263_CR5","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/j.hrthm.2024.06.010","volume":"21","author":"M Shurrab","year":"2024","unstructured":"Shurrab M, Austin PC, Jackevicius CA, et al. Comparative effectiveness and safety of Apixaban and Rivaroxaban in older patients with atrial fibrillation: A population-based cohort study. Heart Rhythm. 2024;21(12):2397\u2013406. https:\/\/doi.org\/10.1016\/j.hrthm.2024.06.010.","journal-title":"Heart Rhythm"},{"issue":"4","key":"2263_CR6","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.hrthm.2024.08.033","volume":"22","author":"M Shurrab","year":"2025","unstructured":"Shurrab M, Austin PC, Jackevicius CA, et al. Apixaban vs Rivaroxaban in patients with atrial fibrillation at high or low bleeding risk: A population-based cohort study. Heart Rhythm. 2025;22(4):961\u201370. https:\/\/doi.org\/10.1016\/j.hrthm.2024.08.033.","journal-title":"Heart Rhythm"},{"issue":"FI1","key":"2263_CR7","doi-asserted-by":"publisher","first-page":"F11","DOI":"10.1093\/EHJCVP\/PVAB002","volume":"7","author":"D Menichelli","year":"2021","unstructured":"Menichelli D, Del Sole F, Di Rocco A, et al. Real-world safety and efficacy of direct oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of 605 771 patients. Eur Heart J Cardiovasc Pharmacother. 2021;7(FI1):F11\u20139. https:\/\/doi.org\/10.1093\/EHJCVP\/PVAB002.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"4","key":"2263_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1161\/CIRCULATIONAHA.123.066485","volume":"149","author":"LPT Joosten","year":"2024","unstructured":"Joosten LPT, Van Doorn S, Van De Ven PM, et al. Safety of switching from a vitamin K antagonist to a Non-Vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomized controlled trial. Circulation. 2024;149(4):279\u201389. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.066485.","journal-title":"Circulation"},{"issue":"4","key":"2263_CR9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135\/SUPPL_FILE\/PRISMA_FIGURE-S1.DOC","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264\u20139. https:\/\/doi.org\/10.7326\/0003-4819-151-4-200908180-00135\/SUPPL_FILE\/PRISMA_FIGURE-S1.DOC.","journal-title":"Ann Intern Med"},{"key":"2263_CR10","unstructured":"Tool to Assess Risk of Bias in Cohort Studies DistillerSR - DistillerSR. https:\/\/www.distillersr.com\/resources\/methodological-resources\/tool-to-assess-risk-of-bias-in-cohort-studies-distillersr Accessed 18 Jul 2025."},{"issue":"7454","key":"2263_CR11","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","volume":"328","author":"Grading quality of evidence and strength of recommendations","year":"2004","unstructured":"Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490. https:\/\/doi.org\/10.1136\/bmj.328.7454.1490.","journal-title":"BMJ"},{"issue":"3","key":"2263_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388. https:\/\/doi.org\/10.1016\/0197-2456(86)90046-2.","journal-title":"Control Clin Trials"},{"key":"2263_CR13","unstructured":"Review Manager. (RevMan) Version 5.4. Published online 2024."},{"key":"2263_CR14","doi-asserted-by":"publisher","unstructured":"Wilkinson C, Wu J, Searle SD, et al. Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial. BMC Med. 2020;18(1). https:\/\/doi.org\/10.1186\/S12916-020-01870-W.","DOI":"10.1186\/S12916-020-01870-W"},{"issue":"1","key":"2263_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/EHJQCCO\/QCAD019","volume":"10","author":"M Grymonprez","year":"2024","unstructured":"Grymonprez M, Petrovic M, De Backer TL, Steurbaut S, Lahousse L. Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study. Eur Heart J Qual Care Clin Outcomes. 2024;10(1):55\u201365. https:\/\/doi.org\/10.1093\/EHJQCCO\/QCAD019.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"6","key":"2263_CR16","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1161\/STROKEAHA.121.036757","volume":"53","author":"D Kim","year":"2022","unstructured":"Kim D, Yang PS, Sung JH, et al. Effectiveness and safety of anticoagulation therapy in frail patients with atrial fibrillation. Stroke. 2022;53(6):1873\u201382. https:\/\/doi.org\/10.1161\/STROKEAHA.121.036757.","journal-title":"Stroke"},{"issue":"1","key":"2263_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/JOIM.13140","volume":"289","author":"GYH Lip","year":"2021","unstructured":"Lip GYH, Keshishian AV, Kang AL, et al. Oral anticoagulants for nonvalvular atrial fibrillation in frail elderly patients: insights from the ARISTOPHANES study. J Intern Med. 2021;289(1):42\u201352. https:\/\/doi.org\/10.1111\/JOIM.13140.","journal-title":"J Intern Med"},{"issue":"6","key":"2263_CR18","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/JOA3.12231","volume":"35","author":"M Shinohara","year":"2019","unstructured":"Shinohara M, Wada R, Yao S, et al. Evaluation of oral anticoagulants in atrial fibrillation patients over 80 years of age with nonsevere frailty. J Arrhythm. 2019;35(6):795\u2013803. https:\/\/doi.org\/10.1002\/JOA3.12231.","journal-title":"J Arrhythm"},{"key":"2263_CR19","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1016\/S1878-7649(14)70156-1","volume":"5","author":"AR Gomez Quintanilla","year":"2014","unstructured":"Gomez Quintanilla AR, Paredes Galan E, Guitian Gonzalez A, Vilches Moraga A, Rodriguez Pascual C. O4.03: Dabigatran etexilate and Rivaroxaban show different safety and efficacy profile in very elderly patients with Non valvular atrial fibrillation. Eur Geriatr Med. 2014;5:S72. https:\/\/doi.org\/10.1016\/S1878-7649(14)70156-1.","journal-title":"Eur Geriatr Med"},{"issue":"7","key":"2263_CR20","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1097\/MLR.0000000000000729","volume":"55","author":"JB Segal","year":"2017","unstructured":"Segal JB, Chang HY, Du Y, Walston JD, Carlson MC, Varadhan R. Development of a Claims-based frailty indicator anchored to a Well-established frailty phenotype. Med Care. 2017;55(7):716\u201322. https:\/\/doi.org\/10.1097\/MLR.0000000000000729.","journal-title":"Med Care"},{"issue":"5","key":"2263_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1503\/CMAJ.050051","volume":"173","author":"K Rockwood","year":"2005","unstructured":"Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ Can Med Association J. 2005;173(5):489\u201395. https:\/\/doi.org\/10.1503\/CMAJ.050051.","journal-title":"CMAJ Can Med Association J"},{"issue":"10132","key":"2263_CR22","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/S0140-6736(18)30668-8","volume":"391","author":"T Gilbert","year":"2018","unstructured":"Gilbert T, Neuburger J, Kraindler J, et al. Development and validation of a hospital frailty risk score focusing on older people in acute care settings using electronic hospital records: an observational study. Lancet. 2018;391(10132):1775\u201382. https:\/\/doi.org\/10.1016\/S0140-6736(18)30668-8.","journal-title":"Lancet"},{"issue":"3","key":"2263_CR23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/AGEING\/AFW039","volume":"45","author":"A Clegg","year":"2016","unstructured":"Clegg A, Bates C, Young J, et al. Development and validation of an electronic frailty index using routine primary care electronic health record data. Age Ageing. 2016;45(3):353\u201360. https:\/\/doi.org\/10.1093\/AGEING\/AFW039.","journal-title":"Age Ageing"},{"issue":"6","key":"2263_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4022\/JAFIB.1870","volume":"10","author":"Z Oqab","year":"2018","unstructured":"Oqab Z, Pournazari P, Sheldon RS. What is the impact of frailty on prescription of anticoagulation in elderly patients with atrial fibrillation? A systematic review and meta-analysis. J Atr Fibrillation. 2018;10(6):1\u20135. https:\/\/doi.org\/10.4022\/JAFIB.1870.","journal-title":"J Atr Fibrillation"},{"issue":"19","key":"2263_CR25","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/j.jacc.2018.03.023","volume":"71","author":"A Qamar","year":"2018","unstructured":"Qamar A, Vaduganathan M, Greenberger NJ, Giugliano RP. Oral anticoagulation in patients with liver disease. J Am Coll Cardiol. 2018;71(19):2162\u201375. https:\/\/doi.org\/10.1016\/j.jacc.2018.03.023.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2263_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/BCP.12054","volume":"76","author":"D Kubitza","year":"2013","unstructured":"Kubitza D, Roth A, Becka M, et al. Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct factor Xa inhibitor. Br J Clin Pharmacol. 2013;76(1):89\u201398. https:\/\/doi.org\/10.1111\/BCP.12054.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"2263_CR27","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","volume":"149","author":"JA Joglar","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: A report of the American college of Cardiology\/American heart association joint committee on clinical practice guidelines. Circulation. 2024;149(1):e1\u2013156.","journal-title":"Circulation"},{"issue":"12","key":"2263_CR28","first-page":"1847","volume":"36","author":"JG Andrade","year":"2020","unstructured":"Andrade JG, Aguilar M, Atzema C, et al. The 2020 Canadian cardiovascular society\/Canadian heart rhythm society comprehensive guidelines for the management of atrial fibrillation. Can J Cardiol. 2020;36(12):1847\u2013948.","journal-title":"Can J Cardiol"},{"issue":"36","key":"2263_CR29","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/EURHEARTJ\/EHAE176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Kotecha D, Rienstra M, et al. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European association for Cardio-Thoracic surgery (EACTS). Eur Heart J. 2024;45(36):3314\u2013414. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHAE176.","journal-title":"Eur Heart J"},{"issue":"3","key":"2263_CR30","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1161\/CIRCULATIONAHA.114.013267\/-\/DC1","volume":"132","author":"M Sharma","year":"2015","unstructured":"Sharma M, Cornelius VR, Patel JP, Davies JG, Molokhia M. Efficacy and harms of direct oral anticoagulants in the elderly for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism: systematic review and meta-analysis. Circulation. 2015;132(3):194\u2013204. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.013267\/-\/DC1.","journal-title":"Circulation"},{"issue":"2","key":"2263_CR31","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1080\/08998280.2022.2155926","volume":"36","author":"R Desai","year":"2022","unstructured":"Desai R, Li A, Mondal A, et al. Direct oral anticoagulants versus vitamin K antagonist (Warfarin) for stroke prevention in frail patients with atrial fibrillation: A Meta-Analysis. Proc (Bayl Univ Med Cent). 2022;36(2):274. https:\/\/doi.org\/10.1080\/08998280.2022.2155926.","journal-title":"Proc (Bayl Univ Med Cent)"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-026-02263-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-026-02263-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-026-02263-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:54:41Z","timestamp":1792572881000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-026-02263-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["2263"],"URL":"https:\/\/doi.org\/10.1007\/s10840-026-02263-4","relation":{},"ISSN":["1572-8595"],"issn-type":[{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}